Is MCEM11 worth it? Analysis of Mérito Cemitérios FII
Recommendation: SELL · Rating 3.0/10
Analysis and recommendation
The MCEM11 is going through a structural liquidity and governance crisis: in June 2026, the fund was compulsorily migrated from B3 to the over-the-counter (OTC) market, virtually eliminating unitholder liquidity. Compounding this are the suspension of distributions since April 2026 (with no timeline for resumption) and a unit price at a historical low of R$ 26.97 following a -54% drop over 12 months. The niche thesis (Brazil's only funeral real estate fund (FII), a 25-year concession with 5 São Paulo cemeteries) remains valid from a strategic standpoint, but execution is being severely tested by municipal bureaucracy delaying the grave maintenance fee — the primary revenue catalyst. With only 228 qualified unitholders and daily liquidity of R$ 16k, this fund is becoming virtually inaccessible to the market. Avoid new positions until there is clarity on the resumption of distributions and potential relisting.
Investment thesis
The MCEM11 was born with a unique and genuine thesis in the Brazilian real estate fund (FII) market: investing in the concession of municipal cemeteries in São Paulo — an asset with inelastic demand, a 25-year contract with the City, and low correlation to the traditional real estate cycle. The strategic thesis remains intact, but execution is being severely tested by two factors: municipal bureaucracy delaying the main revenue catalyst (grave maintenance fee) and the OTC delisting in Jun/2026, which virtually eliminated liquidity and deteriorated the fund's governance profile.
Who it's for
Qualified Investors with a minimum time horizon of 5+ years and conviction in the death-care thesis
Investors who are already positioned and understand the risk of exiting the OTC market
A very aggressive profile accepting the total absence of income for an indefinite period
Those with high tolerance for municipal regulatory/bureaucratic risk
Who it's not for
Investors who need consistent monthly income — distributions suspended with no timeline
Those who do not have a Qualified Investor profile
Investors who need liquidity — R$ 16k/day volume on the OTC market
Those seeking price transparency — OTC price may not reflect actual trades
Any investor who does not understand the risks of OTC delisting and potential loss of tax benefits
Points of attention and risks
LITE ANALYSIS — 180-day window (Jan–Jul/2026)
This is a V3-LITE analysis based on mining 119 documents from the last 180 days plus web context. Documents prior to January 2026 were considered at a summary level only. A complete V3 analysis is recommended prior to any investment decision.
DELISTING — compulsory migration from B3 to the over-the-counter market (Jun/2026)
In June 2026, MCEM11 (Subclass P) and MCEM15 (Subclass O) were compulsorily migrated from the B3 listed market to the OTC over-the-counter market. Trading suspension on the listed market on 06/19/2026; trading enabled on the OTC market on 06/29/2026. New tickers: MCEM11 → 5026026SNR and MCEM15 → 5026026SUB. The delisting was approved at an extraordinary unitholders' meeting by formal consultation tabulated on 06/08/2026. Post-delisting unit prices may not reflect actual trades given negligible liquidity.
Distributions suspended since April/2026 — no timeline for resumption
The fund did not distribute earnings in April, May, and June 2026. The fixed cumulative distribution of R$ 0.67/month continues to accumulate for future payment, but without sufficient cash flow visibility until the grave maintenance fee is approved by the City of São Paulo.
Extremely low liquidity — R$ 16k/day
Daily liquidity of R$ 16k/day is negligible, making it virtually impossible to establish or unwind any meaningful position without significant price impact. With only 228 qualified unitholders and migration to the OTC market, the fund is becoming inaccessible to the retail market.
-54% drop in 12 months — unit price at historical low
The unit price dropped from R$ 66.26 (52-week high) to R$ 26.97 (52-week low, current level). The drop is directly associated with the OTC delisting process and distribution suspension. There is no clear market support at this level given the illiquid context.
Risk of losing tax exemption for individual investors
Income tax exemption for individual investors in real estate investment funds (FIIs) requires (among others): a minimum of 50 unitholders and units traded on an organized market. With only 228 unitholders and migration to the over-the-counter market (which may not qualify as an 'organized market' under the same terms as B3), there is a real risk of losing the tax benefit for individual unitholders.
Maintenance fee only in 2027+ (best case)
Santo Amaro (works completed Nov/2025) is still awaiting inspection by the City of São Paulo to begin collection. Araçá had its project approved only in Apr/2026. Dom Bosco and Vila Nova Cachoeirinha are still under construction. The maintenance fee — the main incremental revenue catalyst of R$ 30–40M/year — has been postponed to 2027 in the best-case scenario.
Extreme concentration — 98.9% of net assets in a single special purpose entity (SPE)
Virtually all of the fund's assets are in the special purpose entity (SPE) Consórcio Cortel SP. Any operational, contractual, or regulatory issue with the concession impacts the fund entirely without any cushion.
Is MCEM11 trustworthy?
Our current reading of MCEM11 is SELL, with a score of 3.0/10. This score comes neither from the manager nor the administrator: it is Rico aos Poucos' editorial assessment, built from the documents the fund files with the CVM. Below is what supports it — and what argues against it.
6th of 9: Cemetery real estate fund (FII) delisted to the over-the-counter (OTC) market in Jun/2026, with distributions suspended since April and a -54% drop over 12 months. Liquidity of ~R$ 16k/day makes establishing or unwinding positions unfeasible — a clear sell case despite the historical dividend yield of 21%.
Risks that don't show up in MCEM11's fact sheet
Potential loss of tax exemption for individual investors
Following migration to the OTC market, the fund is no longer traded on the organized B3 market. Law 11,033/2004 requires, among other criteria, that units be traded on 'stock exchanges or an organized over-the-counter market'. The OTC market may not fit this definition, creating a risk of taxation for individual unitholders.
Consult a tax advisor before any transaction. Await formal guidance from CVM/RFB on classification.
Valuation by equity accounting without an independent appraisal report
SPE Consórcio Cortel SP is valued using the equity accounting method (book value), without a public independent valuation. The actual value of the concession may diverge significantly from book value, especially in a scenario of catalyst delays.
Request an independent valuation report for the SPE via unitholders' meeting.
Reliance on Grupo Cortel for operations
Grupo Cortel operates the cemeteries via the SPE. Operational, labor, or financial crises at the group would directly impact the fund's revenue without a cushion.
Performance fee over CDI in a high Selic environment
With the Selic rate above 14%, the CDI benchmark is difficult to outperform. If the maintenance fee boosts earnings, part of it may be consumed by the 20% performance fee on the excess.
Structural — part of the fund's bylaws.
Scenarios for MCEM11
Scenario
Description
City approves maintenance fee (Santo Amaro) in 2027
Santo Amaro undergoes inspection and receives authorization to collect the maintenance fee. Incremental revenue of ~R$ 8–10M/year (Santo Amaro section). Fund resumes distributions and pays accumulated cumulative balance.
Relisting — return to the B3 listed market
Fund succeeds in reversing the delisting and returning to the listed market. Liquidity returns, tax benefits for individual investors are guaranteed, unit price may recover.
City bureaucracy postpones maintenance fee to 2028+
History shows the City took 2 years just to approve the first construction project. The maintenance fee may be delayed another cycle. Distributions suspended for over 2 years, cumulative distribution accumulating.
Permanent loss of tax exemption for individual investors + deterioration of the unitholder base
Individual unitholders migrate/sell positions due to the loss of tax exemption. Unitholder base drops below 50 (legal minimum). Fund completely loses tax-exempt status.
Conclusion
The MCEM11 is going through the most critical moment in its short history. The compulsory transfer to the OTC over-the-counter market in June/2026 — combined with the suspension of distributions since April and a -54% drop over 12 months — has turned a pioneering niche fund into an asset that is virtually inaccessible to the market.
The business thesis remains strategically valid: a 25-year concession of 5 historical cemeteries in São Paulo, featuring inelastic demand and potential incremental revenue of R$ 30–40M/year when the tomb maintenance fee is approved by City Hall. The problem is that this catalyst has been blocked by municipal bureaucracy for over 18 months — and the history of delays (2 years to approve the first construction project) suggests that 2027 is an optimistic scenario.
For unitholders already positioned, the decision to hold or exit is complex: exiting on the OTC market with R$ 16k/day in liquidity is traumatic and may not reflect the concession's actual value. Holding means living with zero income for an indefinite period and additional tax risk. There is no good answer — only a choice between different risks.
For new investors, the recommendation is clear: AVOID until there is concrete signaling of the resumption of distributions, approval of the maintenance fee by City Hall, or reversal of the transfer to the listed market.
Frequently asked questions
Is MCEM11 good? Is it worth investing?
Current recommendation: SELL. Rating 3.0/10. The MCEM11 is going through a structural liquidity and governance crisis : in June 2026, the fund was compulsorily migrated from B3 to the over-the-counter (OTC) market, virtually eliminating unitholder liquidity. Compounding this are the suspension of distributions since April…
MCEM11: buy or sell?
Our current read on MCEM11 is “SELL”. Rating 3.0/10. Assess it against your risk profile and the points of attention listed above.
What are MCEM11's risks?
The main points of attention for Mérito Cemitérios FII include: LITE ANALYSIS — 180-day window (Jan–Jul/2026); DELISTING — compulsory migration from B3 to the over-the-counter market (Jun/2026); Distributions suspended since April/2026 — no timeline for resumption; Extremely low liquidity — R$ 16k/day.
Who is MCEM11 suitable for?
MCEM11 is suitable for: Qualified Investors with a minimum time horizon of 5+ years and conviction in the death-care thesis Investors who are already positioned and understand the risk of exiting the OTC market A very aggressive profile accepting the total absence of income for an indefinite period